Get Real Time Here
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.430 | 0.1000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Oppenheimer | Mark Breidenbach | Reiterates | OutperformOutperform | Maintains | - | 25.00 |
| 2023-08-07 | Chardan Capital | Geulah Livshits | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-08-04 | Morgan Stanley | Jeffrey Hung | Maintains | Equal-WeightEqual-Weight | Maintains | 14.00 | 14.00 |
| 2023-06-26 | Oppenheimer | Mark Breidenbach | Assumes | Outperform | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMRX | Immuneering | -2.46% | 220.7M |
| RENB | Renovaro Biosciences | -2.6% | 238.9M |
| IPHA | Innate Pharma | 2.99% | 222.2M |
| CELC | Celcuity | -0.8% | 217.8M |
| EGRX | Eagle Pharmaceuticals | 3.48% | 204.7M |
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro Biosciences (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Celcuity (NASDAQ:CELC), Eagle Pharmaceuticals (NASDAQ:EGRX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.
Does Immuneering (IMRX) pay a dividend?
There is no dividend information for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.430 | 0.1000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Oppenheimer | Mark Breidenbach | Reiterates | OutperformOutperform | Maintains | - | 25.00 |
| 2023-08-07 | Chardan Capital | Geulah Livshits | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-08-04 | Morgan Stanley | Jeffrey Hung | Maintains | Equal-WeightEqual-Weight | Maintains | 14.00 | 14.00 |
| 2023-06-26 | Oppenheimer | Mark Breidenbach | Assumes | Outperform | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMRX | Immuneering | -2.46% | 220.7M |
| RENB | Renovaro Biosciences | -2.6% | 238.9M |
| IPHA | Innate Pharma | 2.99% | 222.2M |
| CELC | Celcuity | -0.8% | 217.8M |
| EGRX | Eagle Pharmaceuticals | 3.48% | 204.7M |
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro Biosciences (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Celcuity (NASDAQ:CELC), Eagle Pharmaceuticals (NASDAQ:EGRX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.
Does Immuneering (IMRX) pay a dividend?
There is no dividend information for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.430 | 0.1000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Oppenheimer | Mark Breidenbach | Reiterates | OutperformOutperform | Maintains | - | 25.00 |
| 2023-08-07 | Chardan Capital | Geulah Livshits | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-08-04 | Morgan Stanley | Jeffrey Hung | Maintains | Equal-WeightEqual-Weight | Maintains | 14.00 | 14.00 |
| 2023-06-26 | Oppenheimer | Mark Breidenbach | Assumes | Outperform | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMRX | Immuneering | -2.46% | 220.7M |
| RENB | Renovaro Biosciences | -2.6% | 238.9M |
| IPHA | Innate Pharma | 2.99% | 222.2M |
| CELC | Celcuity | -0.8% | 217.8M |
| EGRX | Eagle Pharmaceuticals | 3.48% | 204.7M |
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro Biosciences (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Celcuity (NASDAQ:CELC), Eagle Pharmaceuticals (NASDAQ:EGRX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.
Does Immuneering (IMRX) pay a dividend?
There is no dividend information for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.430 | 0.1000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Oppenheimer | Mark Breidenbach | Reiterates | OutperformOutperform | Maintains | - | 25.00 |
| 2023-08-07 | Chardan Capital | Geulah Livshits | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-08-04 | Morgan Stanley | Jeffrey Hung | Maintains | Equal-WeightEqual-Weight | Maintains | 14.00 | 14.00 |
| 2023-06-26 | Oppenheimer | Mark Breidenbach | Assumes | Outperform | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMRX | Immuneering | -2.46% | 220.7M |
| RENB | Renovaro Biosciences | -2.6% | 238.9M |
| IPHA | Innate Pharma | 2.99% | 222.2M |
| CELC | Celcuity | -0.8% | 217.8M |
| EGRX | Eagle Pharmaceuticals | 3.48% | 204.7M |
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro Biosciences (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Celcuity (NASDAQ:CELC), Eagle Pharmaceuticals (NASDAQ:EGRX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.
Does Immuneering (IMRX) pay a dividend?
There is no dividend information for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.430 | 0.1000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Oppenheimer | Mark Breidenbach | Reiterates | OutperformOutperform | Maintains | - | 25.00 |
| 2023-08-07 | Chardan Capital | Geulah Livshits | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-08-04 | Morgan Stanley | Jeffrey Hung | Maintains | Equal-WeightEqual-Weight | Maintains | 14.00 | 14.00 |
| 2023-06-26 | Oppenheimer | Mark Breidenbach | Assumes | Outperform | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMRX | Immuneering | -2.46% | 220.7M |
| RENB | Renovaro Biosciences | -2.6% | 238.9M |
| IPHA | Innate Pharma | 2.99% | 222.2M |
| CELC | Celcuity | -0.8% | 217.8M |
| EGRX | Eagle Pharmaceuticals | 3.48% | 204.7M |
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro Biosciences (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Celcuity (NASDAQ:CELC), Eagle Pharmaceuticals (NASDAQ:EGRX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.
Does Immuneering (IMRX) pay a dividend?
There is no dividend information for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.430 | 0.1000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Oppenheimer | Mark Breidenbach | Reiterates | OutperformOutperform | Maintains | - | 25.00 |
| 2023-08-07 | Chardan Capital | Geulah Livshits | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-08-04 | Morgan Stanley | Jeffrey Hung | Maintains | Equal-WeightEqual-Weight | Maintains | 14.00 | 14.00 |
| 2023-06-26 | Oppenheimer | Mark Breidenbach | Assumes | Outperform | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMRX | Immuneering | -2.46% | 220.7M |
| RENB | Renovaro Biosciences | -2.6% | 238.9M |
| IPHA | Innate Pharma | 2.99% | 222.2M |
| CELC | Celcuity | -0.8% | 217.8M |
| EGRX | Eagle Pharmaceuticals | 3.48% | 204.7M |
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro Biosciences (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Celcuity (NASDAQ:CELC), Eagle Pharmaceuticals (NASDAQ:EGRX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.
Does Immuneering (IMRX) pay a dividend?
There is no dividend information for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.430 | 0.1000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Oppenheimer | Mark Breidenbach | Reiterates | OutperformOutperform | Maintains | - | 25.00 |
| 2023-08-07 | Chardan Capital | Geulah Livshits | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-08-04 | Morgan Stanley | Jeffrey Hung | Maintains | Equal-WeightEqual-Weight | Maintains | 14.00 | 14.00 |
| 2023-06-26 | Oppenheimer | Mark Breidenbach | Assumes | Outperform | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMRX | Immuneering | -2.46% | 220.7M |
| RENB | Renovaro Biosciences | -2.6% | 238.9M |
| IPHA | Innate Pharma | 2.99% | 222.2M |
| CELC | Celcuity | -0.8% | 217.8M |
| EGRX | Eagle Pharmaceuticals | 3.48% | 204.7M |
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro Biosciences (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Celcuity (NASDAQ:CELC), Eagle Pharmaceuticals (NASDAQ:EGRX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.
Does Immuneering (IMRX) pay a dividend?
There is no dividend information for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.430 | 0.1000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Oppenheimer | Mark Breidenbach | Reiterates | OutperformOutperform | Maintains | - | 25.00 |
| 2023-08-07 | Chardan Capital | Geulah Livshits | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-08-04 | Morgan Stanley | Jeffrey Hung | Maintains | Equal-WeightEqual-Weight | Maintains | 14.00 | 14.00 |
| 2023-06-26 | Oppenheimer | Mark Breidenbach | Assumes | Outperform | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMRX | Immuneering | -2.46% | 220.7M |
| RENB | Renovaro Biosciences | -2.6% | 238.9M |
| IPHA | Innate Pharma | 2.99% | 222.2M |
| CELC | Celcuity | -0.8% | 217.8M |
| EGRX | Eagle Pharmaceuticals | 3.48% | 204.7M |
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro Biosciences (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Celcuity (NASDAQ:CELC), Eagle Pharmaceuticals (NASDAQ:EGRX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.
Does Immuneering (IMRX) pay a dividend?
There is no dividend information for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open7.700 | Close- |
| Vol / Avg.6.847K / 97.184K | Mkt Cap220.651M |
| Day Range7.420 - 7.700 | 52 Wk Range3.700 - 16.020 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.430 | 0.1000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-08 | Oppenheimer | Mark Breidenbach | Reiterates | OutperformOutperform | Maintains | - | 25.00 |
| 2023-08-07 | Chardan Capital | Geulah Livshits | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-08-04 | Morgan Stanley | Jeffrey Hung | Maintains | Equal-WeightEqual-Weight | Maintains | 14.00 | 14.00 |
| 2023-06-26 | Oppenheimer | Mark Breidenbach | Assumes | Outperform | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMRX | Immuneering | -2.46% | 220.7M |
| RENB | Renovaro Biosciences | -2.6% | 238.9M |
| IPHA | Innate Pharma | 2.99% | 222.2M |
| CELC | Celcuity | -0.8% | 217.8M |
| EGRX | Eagle Pharmaceuticals | 3.48% | 204.7M |
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Renovaro Biosciences (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Celcuity (NASDAQ:CELC), Eagle Pharmaceuticals (NASDAQ:EGRX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.
Does Immuneering (IMRX) pay a dividend?
There is no dividend information for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.